{"entity":{"type":"insider","cik":"0001280044","url":"/insider/0001280044","json_url":"/insider/0001280044.json","name":"GOWEN MAXINE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2004-04-07","last":"2023-08-11","span_basis":"filed_date"},"name_variants":[{"name":"GOWEN MAXINE","source":"filing","n_filings":10,"first_seen":"2004-04-07","last_seen":"2023-08-11"}],"transactions":[{"id":8166975,"accession":"0001415889-23-012145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012145","line_url":"/filing/0001415889-23-012145#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"Aceragen, Inc.","issuer_ticker":"ACGN","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51.0,"shares_display":"51","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":26.01,"total_display":"26.01","total_whole":"26","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-11","scope":"insider"},{"id":2712728,"accession":"0001562180-20-004358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004358","line_url":"/filing/0001562180-20-004358#line-2","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4567.0,"shares_display":"4,567","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":55032.35,"total_display":"55,032.35","total_whole":"55,032","shares_owned_after":24133.0,"shares_owned_after_display":"24,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-09","scope":"insider"},{"id":8723956,"accession":"0001209191-19-007388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-007388","line_url":"/filing/0001209191-19-007388#line-1","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":51000.0,"total_display":"51,000.00","total_whole":"51,000","shares_owned_after":54000.0,"shares_owned_after_display":"54,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-05","scope":"insider"},{"id":2422120,"accession":"0001209191-16-149122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-149122","line_url":"/filing/0001209191-16-149122#line-1","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":51250.0,"total_display":"51,250.00","total_whole":"51,250","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-09","scope":"insider"},{"id":2124727,"accession":"0001179110-16-030454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-030454","line_url":"/filing/0001179110-16-030454#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4102.0,"shares_display":"4,102","price_per_share":2.56,"price_display":"2.56","price_state":"stated","total_value":10501.12,"total_display":"10,501.12","total_whole":"10,501","shares_owned_after":10543.0,"shares_owned_after_display":"10,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":2997111,"accession":"0001209191-16-124434","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-124434","line_url":"/filing/0001209191-16-124434#line-3","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14084.0,"shares_display":"14,084","price_per_share":7.08,"price_display":"7.08","price_state":"stated","total_value":99714.72,"total_display":"99,714.72","total_whole":"99,715","shares_owned_after":293109.0,"shares_owned_after_display":"293,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-27","filed_date":"2016-05-31","scope":"insider"},{"id":2997108,"accession":"0001209191-16-124434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-124434","line_url":"/filing/0001209191-16-124434","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":7.195,"price_display":"7.20","price_state":"stated","total_value":57560.0,"total_display":"57,560.00","total_whole":"57,560","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-31","scope":"insider","n_lines":2},{"id":6878619,"accession":"0001209191-14-074262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-074262","line_url":"/filing/0001209191-14-074262#line-1","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":326025.0,"shares_owned_after_display":"326,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"},{"id":7003216,"accession":"0001209191-14-068701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-068701","line_url":"/filing/0001209191-14-068701#line-1","is_derivative":false,"issuer_cik":"0001280044","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001280044","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":11.819,"price_display":"11.82","price_state":"stated","total_value":15364.7,"total_display":"15,364.70","total_whole":"15,365","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":8866565,"accession":"0001225208-11-010204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-11-010204","line_url":"/filing/0001225208-11-010204#line-1","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7926.0,"shares_display":"7,926","price_per_share":27.2891,"price_display":"27.29","price_state":"stated","total_value":216293.4066,"total_display":"216,293.41","total_whole":"216,293","shares_owned_after":23663.14,"shares_owned_after_display":"23,663.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-21","filed_date":"2011-03-23","scope":"insider"},{"id":434783,"accession":"0001209191-04-019958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-019958","line_url":"/filing/0001209191-04-019958#line-2","is_derivative":false,"issuer_cik":"0001172480","issuer_name":"SANTARUS INC","issuer_ticker":"SNTS","issuer_name_source":null,"issuer_url":"/issuer/0001172480","owner_cik":"0001280044","owner_name":"GOWEN MAXINE","owner_display_name":"GOWEN MAXINE","owner_url":"/insider/0001280044","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-04-06","filed_date":"2004-04-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"Aceragen, Inc.","url":"/issuer/0000861838","role":"Director","n_filings":2,"first_seen":"2016-10-05","last_seen":"2023-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director","n_filings":2,"first_seen":"2014-11-14","last_seen":"2020-06-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Director, Officer (President & CEO)","n_filings":4,"first_seen":"2014-12-10","last_seen":"2019-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000901219","name":"HUMAN GENOME SCIENCES INC","url":"/issuer/0000901219","role":"Director","n_filings":1,"first_seen":"2011-03-23","last_seen":"2011-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001172480","name":"SANTARUS INC","url":"/issuer/0001172480","role":"Director","n_filings":1,"first_seen":"2004-04-07","last_seen":"2004-04-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280044","retrieved_at":"2026-08-26T07:40:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}